204 related articles for article (PubMed ID: 11363227)
1. FDA approves KS drug. Food and Drug Administration. Florida Department of Health and Rehabilitation Services.
AIDS Alert; 1996 Jan; 11(1):11-2. PubMed ID: 11363227
[TBL] [Abstract][Full Text] [Related]
2. DOXIL approved by FDA.
AIDS Patient Care; 1995 Dec; 9(6):306. PubMed ID: 11361446
[No Abstract] [Full Text] [Related]
3. New treatment for KS offers options for therapy.
AIDS Alert; 1996 Feb; 11(2):21-2. PubMed ID: 11363236
[TBL] [Abstract][Full Text] [Related]
4. KS treatment inches forward.
Vazquez E
Posit Aware; 1996; 7(5):9. PubMed ID: 11363790
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma: DaunoXome approved.
AIDS Treat News; 1996 May; (no 246):3-4. PubMed ID: 11363485
[TBL] [Abstract][Full Text] [Related]
6. Doxil receives FDA market clearance.
AIDS Patient Care STDS; 1996 Apr; 10(2):135. PubMed ID: 11361702
[No Abstract] [Full Text] [Related]
7. FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration.
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50-1. PubMed ID: 11363534
[TBL] [Abstract][Full Text] [Related]
8. KS update.
Notes Undergr; 1995; (no 29):4. PubMed ID: 11362282
[TBL] [Abstract][Full Text] [Related]
9. DaunoXome offers KS treatment alternative.
AIDS Alert; 1996 Jun; 11(6):67-8. PubMed ID: 11363544
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel for treating KS.
Proj Inf Perspect; 1997 Nov; (23):15. PubMed ID: 11365372
[TBL] [Abstract][Full Text] [Related]
11. Early approval for two lipid-based drugs.
Baker R
BETA; 1995 Dec; ():4. PubMed ID: 11363009
[TBL] [Abstract][Full Text] [Related]
12. Doxil offers hope to KS sufferers.
Prescott LM
J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):43-4. PubMed ID: 11363097
[TBL] [Abstract][Full Text] [Related]
13. Liposomal chemotherapies.
Smart T
GMHC Treat Issues; 1995; 9(7/8):13. PubMed ID: 11362653
[TBL] [Abstract][Full Text] [Related]
14. KS: a new drug and, maybe, a new bug.
Gilden D
GMHC Treat Issues; 1995 Jan; 9(1):11-12. PubMed ID: 11367378
[TBL] [Abstract][Full Text] [Related]
15. Liposomal KS drugs approved.
GMHC Treat Issues; 1996 Apr; 10(4):8-9. PubMed ID: 11363710
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma.
Amantea MA; Forrest A; Northfelt DW; Mamelok R
Clin Pharmacol Ther; 1997 Mar; 61(3):301-11. PubMed ID: 9084455
[TBL] [Abstract][Full Text] [Related]
17. DOXIL superior for KS.
Posit Aware; 1995; ():7. PubMed ID: 11362576
[TBL] [Abstract][Full Text] [Related]
18. DOXIL approved for KS.
James JS
AIDS Treat News; 1995 Dec; (no 236):6. PubMed ID: 11363051
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma: DOX-SL approval recommended.
AIDS Treat News; 1995 Feb; (no 217):8. PubMed ID: 11362308
[TBL] [Abstract][Full Text] [Related]
20. Liposomal doxorubicin: new preparation. Useful in Kaposi's sarcoma.
Prescrire Int; 1998 Jun; 7(35):69-70. PubMed ID: 10342919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]